Viking Global Investors LP Pro Qr Therapeutics N.V. Transaction History

Viking Global Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2016 May 16, 2016	SELL	N/A	-581,668 Closed	0 $0
Q4 2015 Feb 16, 2016	BUY	N/A	5,036 Added 0.87%	581,668 $5.05 Million
Q3 2015 Nov 16, 2015	SELL	N/A	-18,675 Reduced 3.14%	576,632 $8.4 Million
Q2 2015 Aug 14, 2015	BUY	N/A	186,899 Added 45.76%	595,307 $9.92 Million
Q1 2015 May 15, 2015	BUY	N/A	408,408	408,408 $8.94 Million

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $184M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.